Clinical Trial: FST-100 in the Treatment of Acute Adenoviral Conjunctivitis
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Proof-of-Concept, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of FST-100 Ophthalmic Suspension in the Treatment of Acute Adenoviral Conjunctivitis
Brief Summary: This randomized, double masked, multi-center study is being conducted to support the safety and efficacy of FST-100 for the treatment of acute adenoviral conjunctivitis.
Detailed Summary:
Sponsor: Shire
Current Primary Outcome: Adenoviral eradication and clinical resolution of the infection [ Time Frame: 6-7 days ]
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Shire
Dates:
Date Received: November 9, 2011
Date Started: December 2012
Date Completion:
Last Updated: September 22, 2015
Last Verified: August 2014